Literature DB >> 20216550

Blood-brain barrier permeability for ammonia in patients with different grades of liver fibrosis is not different from healthy controls.

Annemarie Goldbecker1, Ralph Buchert, Georg Berding, Martin Bokemeyer, Ralf Lichtinghagen, Florian Wilke, Björn Ahl, Karin Weissenborn.   

Abstract

Increased blood-brain barrier (BBB) permeability for ammonia is considered to be an integral part of the pathophysiology of hepatic encephalopathy (HE) in patients with liver cirrhosis. Increased glutamate-/glutamine-signal intensity in magnetic resonance spectroscopic studies of the brain in cirrhotic patients was explained as a consequence of increased cerebral ammonia uptake. As similar spectroscopic alterations are present in patients with liver fibrosis, we hypothesized that BBB permeability for ammonia is already increased in liver fibrosis, and thereby contributing to the development of HE. To test this hypothesis, cerebral perfusion and ammonia metabolism were examined through positron emission tomography with (15)O-water, respectively, (13)N-ammonia in patients with Ishak grades 2 and 4 fibrosis, cirrhosis, and healthy controls. There were neither global nor regional differences of cerebral blood flow, the rate constant of unidirectional transport of ammonia from blood into brain tissue, the permeability surface area product of the BBB for ammonia, the net metabolic clearance rate constant of ammonia from blood into glutamine in brain, or the metabolic rate of ammonia. The hypothesis that increased permeability of the BBB for ammonia in patients with liver fibrosis contributes to the later development of HE could not be supported by this study.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20216550      PMCID: PMC2949228          DOI: 10.1038/jcbfm.2010.22

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  28 in total

1.  Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy.

Authors:  A H Lockwood; E W Yap; W H Wong
Journal:  J Cereb Blood Flow Metab       Date:  1991-03       Impact factor: 6.200

2.  Accurate attenuation correction despite movement during PET imaging.

Authors:  J L Andersson; B E Vagnhammar; H Schneider
Journal:  J Nucl Med       Date:  1995-04       Impact factor: 10.057

3.  Factors which affect cerebral uptake and retention of 13NH3.

Authors:  M E Phelps; E J Hoffman; C Raybaud
Journal:  Stroke       Date:  1977 Nov-Dec       Impact factor: 7.914

4.  Metabolic fate of [13N]ammonia in human and canine blood.

Authors:  K C Rosenspire; M Schwaiger; T J Mangner; G D Hutchins; A Sutorik; D E Kuhl
Journal:  J Nucl Med       Date:  1990-02       Impact factor: 10.057

5.  Accurate local blood flow measurements with dynamic PET: fast determination of input function delay and dispersion by multilinear minimization.

Authors:  J van den Hoff; W Burchert; W Müller-Schauenburg; G J Meyer; H Hundeshagen
Journal:  J Nucl Med       Date:  1993-10       Impact factor: 10.057

6.  Blood-brain barrier to ammonia in humans.

Authors:  A H Lockwood; L Bolomey; F Napoleon
Journal:  J Cereb Blood Flow Metab       Date:  1984-12       Impact factor: 6.200

7.  Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data.

Authors:  C S Patlak; R G Blasberg; J D Fenstermacher
Journal:  J Cereb Blood Flow Metab       Date:  1983-03       Impact factor: 6.200

8.  The metabolic fate of 13N-labeled ammonia in rat brain.

Authors:  A J Cooper; J M McDonald; A S Gelbard; R F Gledhill; T E Duffy
Journal:  J Biol Chem       Date:  1979-06-25       Impact factor: 5.157

9.  Calculation of cerebral glucose phosphorylation from brain uptake of glucose analogs in vivo: a re-examination.

Authors:  A Gjedde
Journal:  Brain Res       Date:  1982-06       Impact factor: 3.252

10.  Cerebral extraction of N-13 ammonia: its dependence on cerebral blood flow and capillary permeability -- surface area product.

Authors:  M E Phelps; S C Huang; E J Hoffman; C Selin; D E Kuhl
Journal:  Stroke       Date:  1981 Sep-Oct       Impact factor: 7.914

View more
  12 in total

1.  Ammonia increases paracellular permeability of rat brain endothelial cells by a mechanism encompassing oxidative/nitrosative stress and activation of matrix metalloproteinases.

Authors:  Marta Skowrońska; Magdalena Zielińska; Luiza Wójcik-Stanaszek; Joanna Ruszkiewicz; Dejan Milatovic; Michael Aschner; Jan Albrecht
Journal:  J Neurochem       Date:  2012-02-15       Impact factor: 5.372

Review 2.  Cerebral effects of ammonia in liver disease: current hypotheses.

Authors:  Peter Ott; Hendrik Vilstrup
Journal:  Metab Brain Dis       Date:  2014-02-04       Impact factor: 3.584

Review 3.  13N as a tracer for studying glutamate metabolism.

Authors:  Arthur J L Cooper
Journal:  Neurochem Int       Date:  2010-11-23       Impact factor: 3.921

4.  Hepatic encephalopathy: An approach to its multiple pathophysiological features.

Authors:  Juan Carlos Perazzo; Silvina Tallis; Amalia Delfante; Pablo Andrés Souto; Abraham Lemberg; Francisco Xavier Eizayaga; Salvador Romay
Journal:  World J Hepatol       Date:  2012-03-27

5.  Mitochondrial Changes in Rat Brain Endothelial Cells Associated with Hepatic Encephalopathy: Relation to the Blood-Brain Barrier Dysfunction.

Authors:  Krzysztof Milewski; Karolina Orzeł-Gajowik; Magdalena Zielińska
Journal:  Neurochem Res       Date:  2022-08-02       Impact factor: 4.414

Review 6.  Update on cerebral uptake of blood ammonia.

Authors:  Michael Sørensen
Journal:  Metab Brain Dis       Date:  2013-03-13       Impact factor: 3.584

Review 7.  Alterations of blood brain barrier function in hyperammonemia: an overview.

Authors:  Marta Skowrońska; Jan Albrecht
Journal:  Neurotox Res       Date:  2011-08-27       Impact factor: 3.911

8.  Hypoxia Stress Modifies Na+/K+-ATPase, H+/K+-ATPase, [Formula: see text], and nkaα1 Isoform Expression in the Brain of Immune-Challenged Air-Breathing Fish.

Authors:  Mc Subhash Peter; Satheesan Simi
Journal:  J Exp Neurosci       Date:  2017-12-06

9.  Alterations of blood-brain barrier and associated factors in acute liver failure.

Authors:  Wei Cui; Cui-Ming Sun; Pei Liu
Journal:  Gastroenterol Res Pract       Date:  2013-05-26       Impact factor: 2.260

10.  Elevated baseline serum glutamate as a pharmacometabolomic biomarker for acamprosate treatment outcome in alcohol-dependent subjects.

Authors:  H W Nam; V M Karpyak; D J Hinton; J R Geske; A M C Ho; M L Prieto; J M Biernacka; M A Frye; R M Weinshilboum; D-S Choi
Journal:  Transl Psychiatry       Date:  2015-08-18       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.